Skip to content

Tracheobronchial Secretion Removal

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00932776
Enrollment
Unknown
Registered
2009-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2009-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiration, Artificial, Respiratory Insufficiency

Brief summary

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.

Interventions

DEVICETBA care device

Tracheal suction maneuvers are performed according to the indications provided by the TBA care device or to clinical parameters whichever occurs first.

DEVICEControl

In this group suction maneuvers are performed according to clinical indications or on a fixed schedule whichever comes first.

Sponsors

University of Milano Bicocca
Lead SponsorOTHER

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

* age greater than 18 years * presence of an endotracheal tube to provide mechanical ventilation * expected duration of mechanical ventilation greater than 48 hours.

Exclusion criteria

* age \< 18 years, pregnancy * presence of active bronchial bleeding

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026